Yasir B. Al-Wakeel Insider Trading
Get free email notifications about insider trading for Yasir B. Al-Wakeel.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Yasir B. Al-Wakeel. Yasir B. Al-Wakeel is a CFO and Head of Corp Dev in MERRIMACK PHARMACEUTICALS INC ($MACK) and a Chief Financial Officer in Neon Therapeutics, Inc. ($NTGN) and a Chief Financial Officer in Kronos Bio, Inc. ($KRON).
Address: C/O MERRIMACK PHARMACEUTICALS, INC. ONE KENDALL SQUARE, SUITE B7201 CAMBRIDGE 02139 MA
Companies in which Yasir B. Al-Wakeel is an Insider
Kronos Bio, Inc.
Trading Symbol: KRONIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Yasir B. Al-Wakeel: Chief Financial Officer
Holdings: 109,641 shares
Latest Transaction: Dec 11 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
MERRIMACK PHARMACEUTICALS INC
Trading Symbol: MACKIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Yasir B. Al-Wakeel: CFO and Head of Corp Dev
Holdings: 0 shares
Current Value: $0
Latest Transaction: Feb 10 2016
$MACK Market Capitalization: $405.05M
$MACK Previous Close: $3.22
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Neon Therapeutics, Inc.
Trading Symbol: NTGNIndustry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Yasir B. Al-Wakeel: Chief Financial Officer
Holdings: 0 shares
Latest Transaction: May 06 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Yasir B. Al-Wakeel
Sentiment: All, KRON, MACK, NTGN
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Dec 11 2020 | KRON | Kronos Bio, Inc. | Al-Wakeel Yasir B. | Chief Financial Off ... | Option Exercise | A | 30.94 | 108,633 | 3,361,105 | 108,633 | |
Dec 11 2020 | KRON | Kronos Bio, Inc. | Al-Wakeel Yasir B. | Chief Financial Off ... | Grant | A | 0.00 | 72,422 | 0 | 109,641 | 37.2 K to 109.6 K (+194.58 %) |
Oct 16 2020 | KRON | Kronos Bio, Inc. | Al-Wakeel Yasir B. | Chief Financial Off ... | Buy | P | 19.00 | 5,250 | 99,750 | 37,219 | 32 K to 37.2 K (+16.42 %) |
May 06 2020 | NTGN | Neon Therapeutics, ... | Al-Wakeel Yasir B. | Chief Financial Off ... | Option Exercise | D | 6.13 | 100,000 | 613,000 | 0 | |
May 06 2020 | NTGN | Neon Therapeutics, ... | Al-Wakeel Yasir B. | Chief Financial Off ... | Option Exercise | D | 10.20 | 61,031 | 622,516 | 0 | |
May 06 2020 | NTGN | Neon Therapeutics, ... | Al-Wakeel Yasir B. | Chief Financial Off ... | Option Exercise | D | 5.80 | 192,759 | 1,118,002 | 0 | |
May 06 2020 | NTGN | Neon Therapeutics, ... | Al-Wakeel Yasir B. | Chief Financial Off ... | Sell | D | 0.00 | 196,965 | 0 | 0 | 197 K to 0 (-100.00 %) |